| 000 | 01671 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514001252.0 | ||
| 264 | 0 | _c20010719 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a1366-8714 | ||
| 024 | 7 |
_a10.1136/mp.54.3.176 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoppelt-Struebe, M | |
| 245 | 0 | 0 |
_aRegulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins). _h[electronic resource] |
| 260 |
_bMolecular pathology : MP _cJun 2001 |
||
| 300 |
_a176-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aConnective Tissue Growth Factor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGTP Phosphohydrolases _xphysiology |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 |
_aGlomerular Mesangium _xcytology |
| 650 | 0 | 4 | _aGrowth Substances |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aImmediate-Early Proteins _xdrug effects |
| 650 | 0 | 4 | _aIntercellular Signaling Peptides and Proteins |
| 650 | 0 | 4 |
_aLysophospholipids _xpharmacology |
| 650 | 0 | 4 |
_aProtein Prenylation _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xphysiology |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aHahn, A | |
| 700 | 1 | _aIwanciw, D | |
| 700 | 1 | _aRehm, M | |
| 700 | 1 | _aBanas, B | |
| 773 | 0 |
_tMolecular pathology : MP _gvol. 54 _gno. 3 _gp. 176-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/mp.54.3.176 _zAvailable from publisher's website |
| 999 |
_c11307806 _d11307806 |
||